Tandem Diabetes Care Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -13,220.0% | – | – | – | -60.0% | -270.6% | – | – | +18.4% | +12.9% | -413.3% | – | |
| – | +0.2% | +0.3% | +12.4% | -7.3% | +0.8% | +1.6% | +1.3% | +2.9% | +0.0% | +0.2% | -0.8% | – | |
| – | +9.6% | -3.1% | +13.0% | +5.6% | +7.2% | -9.5% | +0.6% | -17.6% | -4.9% | -22.1% | +0.5% | – | |
| – | -239.1% | – | -328.7% | – | -254.2% | – | – | -131.2% | – | – | -1,228.9% | – | |
| – | +408.9% | -83.8% | +45.1% | -19.0% | -41.4% | -3.4% | +109.3% | -34.1% | +63.4% | -6.2% | -35.4% | – | |
| – | -65.8% | -69.5% | -30.0% | +462.0% | – | +83.4% | +532.8% | -64.7% | -172.9% | +1,205.1% | -55.3% | – | |
| – | – | -1,730.4% | -90.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | – | -100.0% | – | |
| – | – | +419.1% | -122.1% | +50.5% | – | -303.6% | +747.1% | -96.0% | – | +10,428.5% | -99.2% | – | |
| – | – | – | -10,264.0% | – | +1,404.8% | -177.5% | – | +164.1% | -104.7% | – | -231.4% | – | |
| – | – | – | – | – | -64.5% | -377.8% | – | – | -25.6% | +54.2% | -908.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.